ClinicalTrials.govpublic full text
Study of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell Lymphoma
b-cell non-hodgkin lymphoma, cd19, non-hodgkin lymphoma, car-t cells, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915980
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.